When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
EYEG - EyeGate Pharma to proceed its lead product pivotal study in dry eye disease
Eyegate Pharmaceuticals Inc.
The FDA has signed off on filing of an Investigational Device Exemption (IDE) application to commence pivotal study of EyeGate Pharmaceuticals's (EYEG-1.6%) lead product candidate, Ocular Bandage Gel eye drop in punctate epitheliopathies (PE).
More news on: EyeGate Pharmaceuticals, Inc., Healthcare stocks news,